CRIS Current Research Information System

PALAZZINI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.882
AS - Asia 5.238
EU - Europa 3.748
SA - Sud America 343
AF - Africa 342
Continente sconosciuto - Info sul continente non disponibili 305
OC - Oceania 9
Totale 15.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.768
VN - Vietnam 1.583
SG - Singapore 1.343
CN - Cina 1.199
IT - Italia 990
GB - Regno Unito 778
DE - Germania 415
HK - Hong Kong 388
SE - Svezia 285
FR - Francia 264
BR - Brasile 239
UA - Ucraina 208
IN - India 195
IE - Irlanda 182
RU - Federazione Russa 165
NL - Olanda 126
CI - Costa d'Avorio 113
FI - Finlandia 88
KR - Corea 87
ZA - Sudafrica 84
JP - Giappone 75
TG - Togo 72
CA - Canada 69
BD - Bangladesh 65
EE - Estonia 59
JO - Giordania 51
PH - Filippine 42
AR - Argentina 38
TH - Thailandia 35
BG - Bulgaria 31
ID - Indonesia 31
AT - Austria 26
TR - Turchia 26
BE - Belgio 23
SC - Seychelles 23
PL - Polonia 22
CH - Svizzera 20
EC - Ecuador 19
MX - Messico 19
PK - Pakistan 19
CO - Colombia 18
IR - Iran 18
TW - Taiwan 18
IQ - Iraq 17
ES - Italia 13
NG - Nigeria 12
GR - Grecia 10
UZ - Uzbekistan 10
EG - Egitto 9
JM - Giamaica 9
VE - Venezuela 8
AU - Australia 7
PY - Paraguay 7
SA - Arabia Saudita 7
AL - Albania 6
CL - Cile 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
MY - Malesia 5
PE - Perù 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
HN - Honduras 4
KE - Kenya 4
LB - Libano 4
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HR - Croazia 3
MK - Macedonia 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
GH - Ghana 2
HU - Ungheria 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BY - Bielorussia 1
CD - Congo 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 15.552
Salva come PNG Salva come JPEG
Città #
Singapore 889
Southend 677
Ashburn 574
Chandler 513
Fairfield 501
Hong Kong 369
San Jose 333
Ho Chi Minh City 323
Hanoi 295
Santa Clara 295
Wilmington 248
Woodbridge 240
Beijing 202
Dong Ket 197
Houston 190
Seattle 183
Dublin 181
Princeton 180
Cambridge 172
Ann Arbor 156
Hefei 156
Bologna 153
Council Bluffs 140
Boardman 114
Abidjan 113
Lauterbourg 97
Jacksonville 94
Milan 94
Los Angeles 86
Padova 78
Nanjing 75
Westminster 74
Lomé 72
Seoul 69
Helsinki 67
Tokyo 67
Turin 63
New York 62
Buffalo 52
Amman 51
Berlin 51
São Paulo 51
Haiphong 45
Da Nang 44
Jinan 40
Shenyang 40
San Diego 39
Dallas 35
Guangzhou 34
Rome 31
Medford 30
Saint Petersburg 29
Sofia 29
Hebei 27
Redondo Beach 27
Jiaxing 26
Changsha 24
Des Moines 24
Brussels 23
Nanchang 23
Munich 22
Shanghai 21
Chicago 20
Hangzhou 19
Bengaluru 18
London 18
Montreal 18
Mülheim 18
Toronto 18
Dearborn 16
Yubileyny 16
Zhengzhou 16
Can Tho 15
Falls Church 15
Florence 15
Frankfurt am Main 15
Phoenix 15
Tianjin 15
Vienna 15
Warsaw 15
Amsterdam 14
Nuremberg 14
Olalla 14
Chengdu 13
Johannesburg 13
Paris 13
Biên Hòa 12
Falkenstein 12
Jakarta 12
Ninh Bình 12
Orem 12
Redmond 12
Taizhou 12
Abeokuta 11
Bern 11
Brooklyn 11
Genoa 11
Lappeenranta 11
Mahé 11
The Dalles 11
Totale 9.749
Salva come PNG Salva come JPEG
Nome #
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 268
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 268
A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 261
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 259
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 256
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 253
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 247
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 238
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 236
Pulmonary Arterial Hypertension associated to connective tissue diseases 229
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 227
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 217
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 216
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 215
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 206
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 205
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 198
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 197
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 193
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 192
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 188
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 186
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 182
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 180
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 179
Anticoagulant treatment in patients with pulmonary arterial hypertension associated with systemic sclerosis: More shadows than lights 179
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 178
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 176
Current therapeutic approaches to pulmonary arterial hypertension. 175
Sildenafil therapy in patients with porto-pulmonary hypertension 171
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 169
Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension 168
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 167
Challenges in pulmonary hypertension: Managing the unexpected 165
Cardiologia pediatrica. Problematiche cliniche 164
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 163
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study 163
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 161
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 161
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 159
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. 159
Rare causes of pulmonary hypertension. Spectrum of radiological findings and review of the literature 158
Pulmonary veno-occlusive disease: the role of CT 156
European guidelines on pulmonary hypertension: What's new? 154
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 152
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 151
[Treatment goals of pulmonary hypertension]. 150
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 150
Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography. 148
Chronic thromboembolic pulmonary disease 147
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 147
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 146
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 146
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 146
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 145
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 144
Pulmonary hypertension due to left heart disease 144
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function 142
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 140
Long-term therapeutic outcomes in pulmonary arterial hypertension 138
The difficult diagnosis of pulmonary vascular disease in heart failure 138
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 138
Epidemiology of patients referred to a specialised pulmonary hypertension center 137
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 137
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 137
Conventional Medical Therapies in the treatment of pulmonary hypertension 136
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 136
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 136
Progressi nel trattamento delle malattie della circolazione polmonare 135
Current medical therapies in pulmonary arterial hypertension 129
Evidence for Kaposi's sarcoma-associated herpes virus infection in patients with idiopathic pulmonary arterial hypertension: a case series and review of the literature 129
Experience with inheritable pulmonary arterial hypertension in a specialised center 129
The burden of comorbidities in pulmonary arterial hypertension 129
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 128
Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension 127
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 126
Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting 126
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial 124
Balloon pulmonary angioplasty after pulmonary thromboendarterectomy 124
Long-term outcomes after pulmonary endarterectomy 123
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism 122
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 120
Pulmonary vascular disease due to left heart disease: How to achieve a more accurate approach beyond the haemodynamic phenotype: Reply 120
Pulmonary hypertension 118
Pulmonary artery intimal sarcoma. Problems in the differential diagnosis. I sarcomi intimali dell'arteria polmonare. Problemi di diagnosi differenziale 118
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 116
Left ventricular dimensions in pulmonary arterial hypertension: haemodynamic and exercise correlations 112
Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: Still waiting for solid evidence 112
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 109
Pulmonary Hypertension: Lessons from Adults 107
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 104
Treatment goals of pulmonary hypertension. 103
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 97
Left main coronary artery extrinsic compression by enlarged pulmonary artery in patients with pulmonary arterial hypertension 92
Severe Precapillary Pulmonary Hypertension Due to Whipple Disease 90
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 88
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 87
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2 82
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 76
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 69
Totale 15.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.205
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.464 0 80 106 134 123 88 43 100 62 118 303 307
2022/20232.045 202 275 94 266 94 171 62 115 416 96 146 108
2023/2024411 36 78 30 43 29 56 23 12 12 33 34 25
2024/20252.346 79 384 259 162 396 105 166 89 42 151 82 431
2025/20265.137 413 463 398 321 582 279 530 154 1.186 418 231 162
2026/2027418 233 185 0 0 0 0 0 0 0 0 0 0
Totale 15.867